What does CUSIP 86877M209 represent in this 13F holders report?

CUSIP 86877M209 is the security identifier for SURF - SURFACE ONCOLOGY INC - COM used to aggregate holder disclosures.

How many institutions held SURF - SURFACE ONCOLOGY INC - COM in Q3 2021?

88 institutional investors reported SURF - SURFACE ONCOLOGY INC - COM for Q3 2021. Use the holders table for investor-level position and value details.

SURFACE ONCOLOGY INC - COM (SURF)

CUSIP: 86877M209

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class: Equity / COM
Total 13F shares: 24,064,590
Share change: +1,475,857
Total reported value: $182,115,210
Put/Call ratio: 43%
Price per share: $7.57
Number of holders: 88
Value change: +$11,239,253
Number of buys: 47
Number of sells: 41

Quarterly Holders Quick Answers

What is CUSIP 86877M209?
CUSIP 86877M209 identifies SURF - SURFACE ONCOLOGY INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2021
Previous quarter: Q2 2021

Recent filing periods for CUSIP 86877M209:

Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021

Institutional Holders of SURFACE ONCOLOGY INC - COM (SURF) as of Q3 2021

As of 30 Sep 2021, SURFACE ONCOLOGY INC - COM (SURF) was held by 88 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,064,590 shares. The largest 10 holders included ARK Investment Management LLC, Atlas Venture Associates IX, LLC, BlackRock Inc., CITADEL ADVISORS LLC, VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, FMR LLC, FARALLON CAPITAL MANAGEMENT LLC, ORBIMED ADVISORS LLC, and MORGAN STANLEY. This page lists 88 institutional shareholders reporting positions in this security for the Q3 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.